CARsgen Therapeutics Holdings Limited (2171.HK)
HKD 14.98
(1.22%)
HKD 14.98
(1.22%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -767.64 Million CNY | 12.9% |
| 2022 | -881.29 Million CNY | -50.39% |
| 2021 | -585.98 Million CNY | -79.18% |
| 2020 | -327.04 Million CNY | -43.82% |
| 2019 | -227.4 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | - CNY | 0.0% |
| 2024 Q1 | - CNY | 100.0% |
| 2023 Q2 | -187.35 Thousand CNY | 0.0% |
| 2023 FY | -785.04 Million CNY | 10.92% |
| 2023 Q3 | -205.17 Thousand CNY | -9.51% |
| 2023 Q1 | -187.35 Thousand CNY | 12.79% |
| 2023 Q4 | -205.17 Thousand CNY | 0.0% |
| 2022 FY | -881.29 Million CNY | -50.39% |
| 2022 Q2 | -187.98 Thousand CNY | 0.0% |
| 2022 Q1 | -187.98 Thousand CNY | -7.51% |
| 2022 Q3 | -214.83 Thousand CNY | -14.28% |
| 2022 Q4 | -214.83 Thousand CNY | 0.0% |
| 2021 Q2 | -118.83 Thousand CNY | 0.0% |
| 2021 Q4 | -174.86 Thousand CNY | 0.0% |
| 2021 Q3 | -174.86 Thousand CNY | -47.15% |
| 2021 Q1 | -118.83 Thousand CNY | -17.07% |
| 2021 FY | -585.98 Million CNY | -79.18% |
| 2020 Q4 | -101.51 Thousand CNY | 0.0% |
| 2020 FY | -327.04 Million CNY | -43.82% |
| 2020 Q2 | -72.82 Thousand CNY | 0.0% |
| 2020 Q1 | -72.82 Thousand CNY | 0.0% |
| 2020 Q3 | -101.51 Thousand CNY | -39.39% |
| 2019 FY | -227.4 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 67.76 Million HKD | 1232.76% |
| CK Life Sciences Int'l., (Holdings) Inc. | 897.95 Million HKD | 185.489% |